AstraZeneca’s vaccine appears to have an advantage when it comes to storage, affordability and distribution, Jefferies analysts said. Skip to content. Main Navigation. Search. Search for: ...

AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.

A large-scale real-world study in the USA has reinforced the effectiveness of Beyfortus (nirsevimab-alip), the respiratory ...

AstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy ...

AstraZeneca said Aug. 20 its antibody cocktail was 77 percent effective in preventing symptomatic COVID-19 during its 5,197-participant trial.

AstraZeneca's latest data analysis affirms effectiveness of its COVID-19 vaccine and is roughly in line with the results released Monday. The latest analysis finds the vaccine to be 76% effective ...

Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...

AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in ...

AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, the company said on ...

The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be ...

AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective’’ in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of ...